Atrium Therapeutics, Inc. Common Stock (RNA) Stock Price

RNAStock

$14.00−70.61%52W

Market Cap$239.48M

P/E—

PEG Ratio—

Div yield—

Beta1.06

RNA Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-92.54%

Price vs S&P 500 (4W)15.49%

VGM Score45.54

Book Value / Share (Quarterly)$13.69

P/TBV (Annual)0.80x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)58.44%

Cash Flow / Share (Quarterly)$-4.06

Price vs S&P 500 (YTD)-93.08%

Net Profit Margin (TTM)-172.89%

EPS (TTM)$-3.86

10-Day Avg Trading Volume0.17M

EPS Excl Extra (TTM)$-3.86

Revenue Growth (5Y)36.26%

EPS (Annual)$-2.89

ROI (Annual)-35.34%

Net Profit Margin (5Y Avg)-1796.59%

Cash / Share (Quarterly)$15.66

Revenue Growth QoQ (YoY)-71.11%

ROA (Last FY)-592.61%

Revenue Growth TTM (YoY)22.02%

EBITD / Share (TTM)$-3.88

ROE (5Y Avg)-28.11%

Operating Margin (TTM)-174.92%

Cash Flow / Share (Annual)$-2.49

P/B Ratio0.90x

P/B Ratio (Quarterly)0.98x

Net Income / Employee (Annual)$-1,053,200

EV / Revenue (TTM)91.25x

Net Interest Coverage (TTM)-2.35x

ROA (TTM)-33.70%

EPS Growth QoQ (YoY)13.99%

EPS Incl Extra (Annual)$-2.89

Current Ratio (Annual)0.07x

Quick Ratio (Quarterly)12.92x

3-Month Avg Trading Volume0.22M

52-Week Price Return-70.61%

Revenue / Employee (TTM)$813,900

Tangible BV / Share (Quarterly)$6.98

P/S Ratio (Annual)11.33x

Asset Turnover (Annual)2.23x

52-Week High$73.06

Operating Margin (5Y Avg)-1959.94%

EPS Excl Extra (Annual)$-2.89

CapEx CAGR (5Y)96.69%

26-Week Price Return-81.30%

Quick Ratio (Annual)0.03x

13-Week Price Return4.45%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)13.04x

Enterprise Value$-56.94M

Revenue / Share Growth (5Y)13.23%

Asset Turnover (TTM)0.02x

Revenue / Employee (Annual)$396,100

Pretax Margin (Annual)-266.64%

Cash / Share (Annual)$8.75

3-Month Return Std Dev38.91%

Net Income / Employee (TTM)$-1,407,100

ROE (Last FY)-36.27%

EPS Basic Excl Extra (Annual)$-2.89

Receivables Turnover (TTM)19.72x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-3.86

ROI (TTM)-44.34%

P/S Ratio (TTM)5.51x

Pretax Margin (5Y Avg)-1796.59%

Revenue / Share (Annual)$1.09

Tangible BV / Share (Annual)$8.29

Price vs S&P 500 (52W)-88.93%

EPS Growth TTM (YoY)8.34%

Year-to-Date Return-81.12%

5-Day Price Return6.07%

EPS Normalized (Annual)$-2.89

ROA (5Y Avg)-24.50%

Net Profit Margin (Annual)-265.88%

Month-to-Date Return20.00%

Cash Flow / Share (TTM)$-2.93

EBITD / Share (Annual)$-2.88

Operating Margin (Annual)-266.58%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-28.11%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-3.86

P/TBV (Quarterly)0.90x

P/B Ratio (Annual)0.76x

Pretax Margin (TTM)-173.26%

Book Value / Share (Annual)$8.29

Price vs S&P 500 (13W)1.65%

Beta1.06x

P/FCF (Annual)3.76x

Revenue / Share (TTM)$2.24

ROE (TTM)-40.30%

52-Week Low$11.13

vGradeC

gGradeC

mGradeD

vgmGradeC

RNA Earnings Surprise History

Q1 26-0.97est. -1.05

Q2 26-1.18est. -0.64

RNA Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

4.14

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
RNAAtrium Therapeutics, Inc. Common Stock	C	C	D	$14.00
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Atrium Therapeutics, Inc. Common Stock

Atrium Therapeutics develops RNA-based therapeutics for genetic forms of cardiomyopathy. The company's proprietary platform uses ligand-based targeting to deliver RNA therapies directly to heart tissue. Current pipeline programs focus on cardiomyopathies associated with PRKAG2 and PLN gene mutations.